June 15, 2023
Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and …
June 13, 2023
Sponsored by Lantern Pharma
Lantern Pharma’s AI-driven drug discovery platform RADR® enables value creation across multiple dimensions of the oncology drug development process: from …
June 13, 2023
The field of pathology has experienced a major shift over the past few decades. This evolution began as early as …
June 11, 2023
Certara, a leader in biosimulation, has recently expanded the horizons of AI in drug discovery with the introduction of artificial …
June 9, 2023
Iktos, a French AI-focused company specializing in new drug design, and Curreio, a Japanese cryo-electron microscopy (cryo-EM) expert, have recently …
June 8, 2023
Needle-free vaccine delivery has emerged as a promising solution to overcome the challenges associated with frozen storage requirements, thereby improving …
June 7, 2023
Incorporating AI in drug discovery is rapidly becoming a common practice in the pharmaceutical industry. The recent undertakings of UK-based …
June 6, 2023
Owkin, an AI biotech firm, is partnering with NanoString Technologies and other notable cancer research institutions to spearhead the MOSAIC …
June 5, 2023
ReproCell, a well-established life sciences company, recently revealed its latest service offering, Pharmacology-AI. This service is the result of a …
June 2, 2023
Seqera Labs, recognized for its secure workflow orchestration software in the life sciences domain, is aligning forces with Genomics England, …
May 31, 2023
In an essential leap forward for the utilization of artificial intelligence (AI) in drug discovery, Insilico Medicine secured Investigational New …
May 31, 2023
XtalPi Inc., a company that uses artificial intelligence (AI) and automation in pharmaceutical technology, is set to collaborate with Eli …
